Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DCTH NASDAQ:NPCE NASDAQ:SGHT NASDAQ:SMLR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDCTHDelcath Systems$10.23-1.4%$11.03$8.87▼$18.23$363.11M0.84991,745 shs1.10 million shsNPCENeuroPace$10.48-0.7%$9.95$5.45▼$18.98$349.01M1.91125,741 shs94,492 shsSGHTSight Sciences$5.28+1.3%$3.82$2.03▼$5.48$272.83M2.41221,663 shs73,576 shsSMLRSemler Scientific$23.96+5.3%$28.63$21.84▼$81.56$344.64M1.411.06 million shs802,079 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDCTHDelcath Systems-1.45%-14.54%-7.25%-10.34%-8.50%NPCENeuroPace-0.66%+0.67%+2.54%+16.70%+77.63%SGHTSight Sciences+1.34%+12.58%+49.15%+51.29%-2.40%SMLRSemler Scientific+5.27%+3.36%-24.23%-37.08%-9.48%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDCTHDelcath Systems$10.23-1.4%$11.03$8.87▼$18.23$363.11M0.84991,745 shs1.10 million shsNPCENeuroPace$10.48-0.7%$9.95$5.45▼$18.98$349.01M1.91125,741 shs94,492 shsSGHTSight Sciences$5.28+1.3%$3.82$2.03▼$5.48$272.83M2.41221,663 shs73,576 shsSMLRSemler Scientific$23.96+5.3%$28.63$21.84▼$81.56$344.64M1.411.06 million shs802,079 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDCTHDelcath Systems-1.45%-14.54%-7.25%-10.34%-8.50%NPCENeuroPace-0.66%+0.67%+2.54%+16.70%+77.63%SGHTSight Sciences+1.34%+12.58%+49.15%+51.29%-2.40%SMLRSemler Scientific+5.27%+3.36%-24.23%-37.08%-9.48%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDCTHDelcath Systems 2.80Moderate Buy$24.00134.60% UpsideNPCENeuroPace 2.57Moderate Buy$16.6058.40% UpsideSGHTSight Sciences 2.25Hold$4.67-11.62% DownsideSMLRSemler Scientific 2.80Moderate Buy$74.25209.89% UpsideCurrent Analyst Ratings BreakdownLatest SGHT, DCTH, NPCE, and SMLR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/24/2025DCTHDelcath SystemsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C-)10/21/2025DCTHDelcath SystemsCraig HallumSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$20.0010/21/2025SGHTSight SciencesLake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$5.00 ➝ $7.0010/21/2025DCTHDelcath SystemsCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$21.0010/20/2025DCTHDelcath SystemsHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy$31.00 ➝ $30.0010/8/2025DCTHDelcath SystemsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C-)10/8/2025NPCENeuroPaceWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025SGHTSight SciencesWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025SMLRSemler ScientificWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)10/7/2025SGHTSight SciencesCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$4.50 ➝ $4.009/27/2025DCTHDelcath SystemsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C-)(Data available from 10/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDCTHDelcath Systems$37.21M9.62N/AN/A$2.15 per share4.76NPCENeuroPace$79.91M4.34N/AN/A$0.27 per share38.81SGHTSight Sciences$79.87M3.46N/AN/A$1.72 per share3.07SMLRSemler Scientific$56.29M6.44$4.71 per share5.09$24.90 per share0.96Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDCTHDelcath Systems-$26.39M$0.05204.60N/AN/A3.18%6.91%5.80%11/4/2025 (Estimated)NPCENeuroPace-$27.14M-$0.84N/AN/AN/A-29.29%-168.61%-25.48%11/4/2025 (Estimated)SGHTSight Sciences-$51.51M-$0.96N/AN/AN/A-64.23%-59.38%-36.43%11/6/2025 (Estimated)SMLRSemler Scientific$40.90M$2.439.86∞N/A86.20%43.84%32.88%11/3/2025 (Estimated)Latest SGHT, DCTH, NPCE, and SMLR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/6/2025Q3 2025SGHTSight Sciences-$0.26N/AN/AN/A$17.74 millionN/A11/4/2025Q3 2025DCTHDelcath Systems-$0.08N/AN/AN/A$23.22 millionN/A11/4/2025Q3 2025NPCENeuroPace-$0.20N/AN/AN/A$24.64 millionN/A11/3/2025Q3 2025SMLRSemler Scientific-$0.1450N/AN/AN/A$7.87 millionN/A8/12/2025Q2 2025NPCENeuroPace-$0.24-$0.26-$0.02-$0.26$23.08 million$23.52 million8/7/2025Q2 2025SGHTSight Sciences-$0.25-$0.23+$0.02-$0.23$18.18 million$19.56 million8/6/2025Q2 2025DCTHDelcath Systems$0.02$0.07+$0.05$0.07$22.84 million$24.16 million8/4/2025Q2 2025SMLRSemler Scientific-$0.27$5.04+$5.31$5.04$8.10 million$8.22 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDCTHDelcath SystemsN/AN/AN/AN/AN/ANPCENeuroPaceN/AN/AN/AN/AN/ASGHTSight SciencesN/AN/AN/AN/AN/ASMLRSemler ScientificN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDCTHDelcath SystemsN/A10.889.87NPCENeuroPace3.025.474.51SGHTSight Sciences0.5710.019.49SMLRSemler Scientific0.250.600.58Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDCTHDelcath Systems61.12%NPCENeuroPace78.83%SGHTSight Sciences55.51%SMLRSemler Scientific49.37%Insider OwnershipCompanyInsider OwnershipDCTHDelcath Systems17.40%NPCENeuroPace20.50%SGHTSight Sciences30.90%SMLRSemler Scientific16.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDCTHDelcath Systems6034.98 million28.89 millionOptionableNPCENeuroPace17033.08 million26.30 millionOptionableSGHTSight Sciences21052.37 million36.19 millionOptionableSMLRSemler Scientific12015.14 million12.66 millionNot OptionableSGHT, DCTH, NPCE, and SMLR HeadlinesRecent News About These CompaniesSemler Scientific Deadline: SMLR Investors Have Opportunity to Lead Semler Scientific, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law FirmOctober 24 at 9:01 PM | myhorrynews.comMSMLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Semler Scientific, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitOctober 24 at 12:00 PM | globenewswire.comSemler Scientific, Inc. (SMLR) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before October 28, 2025October 24 at 10:59 AM | theglobeandmail.comShareholders that lost money on Semler Scientific, Inc.(SMLR) should contact Levi & Korsinsky about pending Class Action - SMLROctober 24 at 9:00 AM | prnewswire.comSEMLER CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Urges Semler Scientific Investors to Contact the Firm Before the October 28th DeadlineOctober 23 at 5:20 PM | globenewswire.comSemler Scientific Inc. (SMLR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitOctober 23 at 3:37 PM | prnewswire.comINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Semler ScientificOctober 23 at 1:19 PM | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Semler Scientific, Inc. of Class Action Lawsuit and Upcoming Deadlines - SMLROctober 23 at 10:00 AM | prnewswire.comThe Gross Law Firm Notifies Semler Scientific, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - SMLROctober 23 at 8:45 AM | prnewswire.comSMLR Investors Have Opportunity to Lead Semler Scientific, Inc. Securities Fraud Lawsuit with the Schall Law FirmOctober 23 at 3:18 AM | prnewswire.comSemler Scientific, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SMLROctober 23 at 3:16 AM | prnewswire.comSMLR Investors Have Opportunity to Lead Semler Scientific, Inc. Securities Fraud Lawsuit with ...October 22 at 8:26 PM | bakersfield.comBSMLR Investors Have Opportunity to Lead Semler Scientific, Inc. Securities Fraud Lawsuit with the Schall Law FirmOctober 22 at 4:23 PM | globenewswire.comInternational Assets Investment Management LLC Makes New Investment in Semler Scientific Inc. $SMLROctober 22 at 4:57 AM | marketbeat.comSemler Scientific Inc. (SMLR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitOctober 21, 2025 | prnewswire.comSMLR DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Semler Scientific, Inc. Investors to Secure Counsel Before Important October 28 Deadline in Securities Class Action First Filed by the Firm – SMLROctober 21, 2025 | globenewswire.comPortnoy Law Firm Announces Class Action on Behalf of Semler Scientific, Inc. InvestorsOctober 21, 2025 | globenewswire.comLevi & Korsinsky Reminds Semler Scientific, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2025 - SMLROctober 21, 2025 | prnewswire.comShareholders that lost money on Semler Scientific, Inc.(SMLR) Urged to Join Class Action – Contact Levi & Korsinsky to Learn MoreOctober 20, 2025 | globenewswire.comSMLR LAWSUIT ALERT: The Gross Law Firm Notifies Semler Scientific, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineOctober 20, 2025 | prnewswire.comSMLR Investors Have Opportunity to Lead Semler Scientific, Inc. Securities Fraud Lawsuit with the Schall Law FirmOctober 20, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSGHT, DCTH, NPCE, and SMLR Company DescriptionsDelcath Systems NASDAQ:DCTH$10.23 -0.15 (-1.45%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$10.34 +0.11 (+1.04%) As of 10/24/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.NeuroPace NASDAQ:NPCE$10.48 -0.07 (-0.66%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$10.50 +0.02 (+0.18%) As of 10/24/2025 07:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.Sight Sciences NASDAQ:SGHT$5.28 +0.07 (+1.34%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$5.28 +0.00 (+0.09%) As of 10/24/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.Semler Scientific NASDAQ:SMLR$23.96 +1.20 (+5.27%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$24.85 +0.89 (+3.71%) As of 10/24/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 10/20 - 10/24 Freeport-McMoRan Posts Strong Earnings Despite Indonesia Shutdown Tesla’s Earnings Review: Does the Juice Justify the Squeeze? Warner Bros. Bidding War Potential: How High Could WBD Shares Go? Fal.Con Europe Could Be CrowdStrike’s Early Earnings Catalyst Logitech Eyes Breakout Before Earnings—Citigroup Sees 30% Upside Boeing Takes Off as FAA Greenlights 737 MAX Production Boost Capital One Just Flashed a Buy Signal—New Highs Could Be Next Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
